Search

everythinglearnresearchcommunity

for

Search:↓

The study concluded that a special imaging technique showed women with hair loss have slower hair growth and a faulty hair replacement cycle.

ULBP3 could be a marker for diagnosing alopecia areata incognita and may be linked to its cause and development.

Iron profile tests are recommended for women with hair loss, as haemoglobin levels alone are not reliable.

Female pattern hair loss is linked to genetics, family history, and lifestyle factors.

Trichoscopy is crucial for accurately diagnosing fibrosing alopecia in pattern distribution.

Older age, family history, and low iron levels increase the risk of female hair loss.

Treat genetic hair loss early with FDA-approved medications and consider hair transplantation.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

Spironolactone is safe for treating female hair loss, but the safety of other drugs is uncertain.

Iron deficiency is the main cause of hair loss in women, and iron supplements started within 6 months can improve hair health.

Nourkrin® Woman with Marilex® improves hair growth, appearance, and confidence in women with hair loss.

Over 40% of postmenopausal women experience hair loss, with treatments aiming to stop further loss and possibly thicken hair.

Most women with hair loss using 5% topical Minoxidil are satisfied with the treatment, but hair loss still affects their daily habits and social life.

Female pattern hair loss is different from male pattern hair loss and has unclear genetic causes.

Ludwig pattern hair loss results from varying androgen sensitivity, causing fewer thick hairs and more thin hairs.

Minoxidil and finasteride can help with hair loss, but more research is needed to improve treatments for certain types of hair loss.

Increased regulatory T cell activity may lead to better outcomes in acute diffuse and total alopecia.

Non-scarring alopecia in females affects emotional well-being and requires accurate diagnosis and personalized treatment.

Hair loss occurs due to fewer papillary cells, smaller follicles, and shorter growth phases.

The unit area trichogram is a reliable method to assess hair loss and treatment response in people with androgenic alopecia by measuring hair density and thickness.

Chinese men have lower AGA rates than Caucasians, with type III vertex most common; family history is important.

Flutamide effectively treats female pattern hair loss with low doses showing good liver tolerance.

AGA more common in men, increases with age, linked to family history, hypertension, dyslipidemia, and smoking.

Low vitamin D might be linked to certain types of hair loss, and supplements could help, but more research is needed.

Black women's unique hair characteristics and styling practices can lead to specific scalp conditions, which require early diagnosis and appropriate treatment.

Chemotherapy caused hair loss with specific patterns, but most patients had hair regrowth after treatment, while some had lasting hair loss.

Hair transplantation is the only permanent solution for female pattern hair loss and can greatly improve quality of life with careful planning.

Trichoscopy effectively diagnoses early female hair loss, but may need scalp biopsy for confirmation.

PRP shows promise for treating female hair loss but needs more research.

New treatments for Frontal Fibrosing Alopecia show promise, especially finasteride and dutasteride, with most patients seeing improvement or stabilization.